Cargando…

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

PURPOSE: Women have more adverse events (AEs) from chemotherapy than men, but few studies have investigated sex differences in immune or targeted therapies. We examined AEs by sex across different treatment domains. METHODS: We analyzed treatment-related AEs by sex in SWOG phase II and III clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unger, Joseph M., Vaidya, Riha, Albain, Kathy S., LeBlanc, Michael, Minasian, Lori M., Gotay, Carolyn C., Henry, N. Lynn, Fisch, Michael J., Lee, Shing M., Blanke, Charles D., Hershman, Dawn L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061143/ https://www.ncbi.nlm.nih.gov/pubmed/35119908 http://dx.doi.org/10.1200/JCO.21.02377

Ejemplares similares

Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
por: Unger, Joseph M., et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation
por: Unger, Joseph M, et al.
Publicado: (2019)

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
por: Unger, Joseph M., et al.
Publicado: (2020)

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials
por: Unger, Joseph M, et al.
Publicado: (2020)

Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2020)

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic
por: Unger, Joseph M., et al.
Publicado: (2021)

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Crew, Katherine D., et al.
Publicado: (2017)

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain: A Randomized Clinical Trial
por: Hershman, Dawn L., et al.
Publicado: (2022)

Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
por: Vaidya, Riha, et al.
Publicado: (2022)

A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
por: Lee, Shing M., et al.
Publicado: (2019)

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms
por: Henry, N Lynn, et al.
Publicado: (2021)

Trends in Medical Aid in Dying in Oregon and Washington
por: Al Rabadi, Luai, et al.
Publicado: (2019)

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
por: Vaidya, Riha, et al.
Publicado: (2023)

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)
por: Louie, S G, et al.
Publicado: (2013)

Patterns of Scientific and Clinical Impact in Cancer Randomized Clinical Trials
por: Nghiem, Van T., et al.
Publicado: (2022)

Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics
por: Bell-Brown, Ari, et al.
Publicado: (2023)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy
por: Yeung, Howa, et al.
Publicado: (2023)

Factors Associated With Patients Not Receiving Oral Anticancer Drugs
por: Doshi, Sahil D., et al.
Publicado: (2022)

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis
por: Xiao, Hong, et al.
Publicado: (2022)

Patients' Perceptions of Physician-Patient Discussions and Adverse Events with Cancer Therapy
por: Hershman, Dawn, et al.
Publicado: (2008)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
por: Jing, Ying, et al.
Publicado: (2022)

Assessment of Survivor Concerns (ASC): A newly proposed brief questionnaire
por: Gotay, Carolyn C, et al.
Publicado: (2007)

Ethnic differential item functioning in the assessment of quality of life in cancer patients
por: Pagano, Ian S, et al.
Publicado: (2005)

Association of Patient, Physician, and Practice-Level Factors with Uptake of Payer-Led Oncology Clinical Pathways
por: Mullangi, Samyukta, et al.
Publicado: (2023)

Supplement use during an intergroup clinical trial for breast cancer (S0221)
por: Zirpoli, Gary R., et al.
Publicado: (2013)

The Relationship between Complementary and Alternative Medicine Use and Breast Cancer Early Detection: A Critical Review
por: Dale, Laura C., et al.
Publicado: (2012)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
por: Mongiovi, Jennifer M., et al.
Publicado: (2018)

A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma
por: Rimsza, Lisa M., et al.
Publicado: (2011)

Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
por: Cannioto, Rikki A., et al.
Publicado: (2023)

Observational Study of the Prevalence of Febrile Neutropenia in Patients Who Received Filgrastim or Pegfilgrastim Associated With 3-4 Week Chemotherapy Regimens in Community Oncology Practices
por: Morrison, Vicki A., et al.
Publicado: (2007)

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
por: Unger, Joseph M, et al.
Publicado: (2020)

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2018)

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials
por: Sedrak, Mina S., et al.
Publicado: (2020)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

38351 Immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
por: Lucas, Margaret Byrnethew, et al.
Publicado: (2021)

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development
por: Peiffer, Daniel S., et al.
Publicado: (2020)

Recovering Hidden Responder Groups in Individuals Receiving Neurofeedback for Tinnitus
por: Riha, Constanze, et al.
Publicado: (2022)

The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?
por: Temkin, Sarah M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o45gflrri8tufn5d2uculhfua1